Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $239.11 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $63.21 | 4 | $0 (2022) |
| SOBI, INC | $40.23 | 2 | $0 (2024) |
| Eisai Inc. | $37.61 | 2 | $0 (2024) |
| PFIZER INC. | $27.48 | 2 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $18.87 | 1 | $0 (2019) |
| Astellas Pharma US Inc | $13.76 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $13.34 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $12.94 | 1 | $0 (2019) |
| TESARO, Inc. | $11.67 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.68 | 2 | Eisai Inc. ($22.19) |
| 2023 | $18.74 | 1 | SOBI, INC ($18.74) |
| 2022 | $20.78 | 1 | Genentech USA, Inc. ($20.78) |
| 2019 | $75.24 | 5 | Genentech USA, Inc. ($28.96) |
| 2018 | $66.91 | 5 | Eisai Inc. ($15.42) |
| 2017 | $13.76 | 1 | Astellas Pharma US Inc ($13.76) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Oncology | ||||||
| 01/18/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/27/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/21/2022 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: BioOncology | ||||||
| 12/10/2019 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: BioOncology | ||||||
| 11/19/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $18.87 | General |
| 09/05/2019 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: BioOncology | ||||||
| 07/30/2019 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Oncology | ||||||
| 11/13/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: Oncology | ||||||
| 10/23/2018 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 08/16/2018 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Oncology | ||||||
| 08/14/2018 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: BioOncology | ||||||
| 01/04/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 12 | 18 | $4,198 | $1,037 |
| 2020 | 1 | 13 | 25 | $5,721 | $1,491 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 18 | $4,198 | $1,037 | 24.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 25 | $5,721 | $1,491 | 26.1% |
About Dr. Satyanarayan Reddy, M.D
Dr. Satyanarayan Reddy, M.D is a Hematology & Oncology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831192236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Satyanarayan Reddy, M.D has received a total of $239.11 in payments from pharmaceutical and medical device companies, with $43.68 received in 2024. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($239.11).
As a Medicare-enrolled provider, Reddy has provided services to 25 Medicare beneficiaries, totaling 43 services with total Medicare billing of $2,528. Data is available for 2 years (2020–2021), covering 2 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Omaha, NE
- Active Since 05/31/2005
- Last Updated 09/12/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1831192236
Products in Payments
- VENCLEXTA (Biological) $63.21
- Lenvima (Drug) $37.61
- DOPTELET (Drug) $21.49
- Doptelet (Drug) $18.74
- IBRANCE (Drug) $14.47
- Xtandi (Drug) $13.76
- DARZALEX (Biological) $13.34
- BOSULIF (Drug) $13.01
- LYNPARZA (Drug) $12.94
- ZEJULA (Drug) $11.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Omaha
James Armitage, Md, MD
Hematology & Oncology — Payments: $1.5M
Margaret Block, M.d, M.D
Hematology & Oncology — Payments: $444,214
Julie Vose, Md, MD
Hematology & Oncology — Payments: $194,187
Peter Silberstein, M.d, M.D
Hematology & Oncology — Payments: $143,878
Apar Kishor Ganti, Md, MD
Hematology & Oncology — Payments: $135,871
Dr. Krishna Gundabolu, M.d, M.D
Hematology & Oncology — Payments: $75,519